Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo The number of sexually transmitted ...
This facility ... local and central CAP/CLIA safety lab, a clinical trial kit processing area, and a 2,500 square foot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback